These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3494612)

  • 1. High efficiency antigen presentation by thyroglobulin-primed murine splenic B cells.
    Hutchings P; Rayner DC; Champion BR; Marshall-Clarke S; Macatonia S; Roitt I; Cooke A
    Eur J Immunol; 1987 Mar; 17(3):393-8. PubMed ID: 3494612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-specific B cells efficiently present low doses of antigen for induction of T cell proliferation.
    Malynn BA; Romeo DT; Wortis HH
    J Immunol; 1985 Aug; 135(2):980-8. PubMed ID: 2409164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro regulation of thyroglobulin (Tg) autoantibody production by Tg-specific T-cell lines and hybridomas.
    Champion BR; Hutchings P; Rayner DC; Page K; Tite J; Cooke A; Roitt IM
    Immunology; 1991 Aug; 73(4):415-20. PubMed ID: 1717368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody conjugates mimic specific B cell presentation of antigen: relationship between T and B cell specificity.
    Ozaki S; Berzofsky JA
    J Immunol; 1987 Jun; 138(12):4133-42. PubMed ID: 2438335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice.
    Kurt-Jones EA; Liano D; HayGlass KA; Benacerraf B; Sy MS; Abbas AK
    J Immunol; 1988 Jun; 140(11):3773-8. PubMed ID: 2453554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoreactive T-cell lines specific for mouse thyroglobulin.
    Champion BR; Varey AM; Katz D; Cooke A; Roitt IM
    Immunology; 1985 Mar; 54(3):513-9. PubMed ID: 2579025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes.
    Ron Y; Sprent J
    J Immunol; 1987 May; 138(9):2848-56. PubMed ID: 2952725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of antigen processing and presentation by resting B lymphocytes.
    Gosselin EJ; Tony HP; Parker DC
    J Immunol; 1988 Mar; 140(5):1408-13. PubMed ID: 3257975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic presentation of an immunoglobulin "tolerogen" requires interleukin 2.
    Sadegh-Nasseri S; Phipps RP
    Eur J Immunol; 1988 Mar; 18(3):417-23. PubMed ID: 2451614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate.
    Hashimoto N; Takatsu K; Masuho Y; Kishida K; Hara T; Hamaoka T
    J Immunol; 1984 Jan; 132(1):129-35. PubMed ID: 6418795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen presentation is a function of all B cell subpopulations separated on the basis of size.
    Jelachich ML; Lakey EK; Casten L; Pierce SK
    Eur J Immunol; 1986 Apr; 16(4):411-6. PubMed ID: 3009203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen presentation by hapten-specific B lymphocytes. III. Analysis of the immunoglobulin-dependent pathway of antigen presentation to interleukin 1-dependent T lymphocytes.
    Rock KL; Haber SI; Liano D; Benacerraf B; Abbas AK
    Eur J Immunol; 1986 Nov; 16(11):1407-12. PubMed ID: 2946591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes.
    Janeway CA; Ron J; Katz ME
    J Immunol; 1987 Feb; 138(4):1051-5. PubMed ID: 3100626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
    J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors.
    Abbas AK; Haber S; Rock KL
    J Immunol; 1985 Sep; 135(3):1661-7. PubMed ID: 2410498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: antigen presentation by rat/mouse hybridoma lines secreting monoclonal antibodies against the nicotinic acetylcholine receptor.
    Zhang YP; Tzartos SJ; Wekerle H
    Eur J Immunol; 1988 Feb; 18(2):211-8. PubMed ID: 2450756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells.
    Pollok KE; Kim YJ; Hurtado J; Zhou Z; Kim KK; Kwon BS
    Eur J Immunol; 1994 Feb; 24(2):367-74. PubMed ID: 8299685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation by hapten-specific B lymphocytes. IV. Comparative ability of B cells to present specific antigen and anti-immunoglobulin antibody.
    Lichtman AH; Tony HP; Parker DC; Abbas AK
    J Immunol; 1987 May; 138(9):2822-5. PubMed ID: 3494773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antigen presentation by lymph node cells from protein and peptide-primed mice.
    Hoyne GF; Callow MG; Kuo MC; Thomas WR
    Immunology; 1993 Jan; 78(1):58-64. PubMed ID: 8436404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptor site(s) for T cell-replacing factor (TRF) on B lymphocytes. II. Activation of B cells by cross-linkage or aggregation of the TRF acceptor molecule.
    Tominaga A; Takatsu K; Hamaoka T
    J Immunol; 1982 Jun; 128(6):2581-5. PubMed ID: 6978908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.